Ambrose A, Welham R T, Cefalo R C
Obstet Gynecol. 1985 Aug;66(2):267-72.
Thrombotic thrombocytopenic purpura during pregnancy in which both mother and fetus have survived has been an exceedingly rare occurrence, due at least in part to the difficulty in distinguishing this uncommon disease from hematologic complications of preeclampsia. In the nonpregnant patient, the use of plasma infusion or exchange plasmapheresis as therapy of choice has resulted in a dramatic increase in survival. By using more specific criteria than the classical clinical pentad, the diagnosis of thrombotic thrombocytopenic purpura during pregnancy can be made with greater accuracy. The first known instance of the successful use of exchange plasmapheresis leading to the survival of both mother and fetus in thrombotic thrombocytopenic purpura clearly not secondary to preeclampsia is reported.
母亲和胎儿均存活的妊娠期血栓性血小板减少性紫癜极为罕见,至少部分原因是难以将这种罕见疾病与先兆子痫的血液学并发症区分开来。在非妊娠患者中,使用血浆输注或置换血浆疗法作为首选治疗方法已使生存率显著提高。通过使用比经典临床五联征更具体的标准,可以更准确地诊断妊娠期血栓性血小板减少性紫癜。本文报道了首例成功使用置换血浆疗法使血栓性血小板减少性紫癜患者的母亲和胎儿均存活的病例,该病例显然并非继发于先兆子痫。